Evidence map›Paper›PMID 35347365›Full record

ArticlePsychopharmacology2022

Sex differences in neurobehavioral consequences of methamphetamine exposure in adult mice.

Delaney L Davis, Daniel B Metzger, Philip H Vann, Jessica M Wong, Kumudu H Subasinghe, Isabelle K Garlotte, Nicole R Phillips, Ritu A Shetty, Michael J Forster, Nathalie Sumien

Open access · greenAbstract read
In one paragraph

Article in Psychopharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Delaney L DavisDepartment of Pharmacology & Neuroscience, UNT HSC, Fort Worth, TX, USA.
Daniel B MetzgerDepartment of Pharmacology & Neuroscience, UNT HSC, Fort Worth, TX, USA.
Philip H VannDepartment of Pharmacology & Neuroscience, UNT HSC, Fort Worth, TX, USA.
Jessica M WongDepartment of Pharmacology & Neuroscience, UNT HSC, Fort Worth, TX, USA.
Kumudu H SubasingheDepartment of Microbiology, Immunology & Genetics, UNT HSC, Fort Worth, TX, USA.
Isabelle K GarlotteDepartment of Microbiology, Immunology & Genetics, UNT HSC, Fort Worth, TX, USA.
Nicole R PhillipsDepartment of Microbiology, Immunology & Genetics, UNT HSC, Fort Worth, TX, USA.
Ritu A ShettyDepartment of Pharmacology & Neuroscience, UNT HSC, Fort Worth, TX, USA.
Michael J ForsterDepartment of Pharmacology & Neuroscience, UNT HSC, Fort Worth, TX, USA.
Nathalie SumienDepartment of Pharmacology & Neuroscience, UNT HSC, Fort Worth, TX, USA. Nathalie.sumien@unthsc.edu.ORCID http://orcid.org/0000-0002-0077-9873
University of North Texas · US

Funding

Training in the Neurobiology of Aging and Alzheimer's DiseaseT32AG020494 · NIA · UNIVERSITY OF NORTH TEXAS HLTH SCI CTR · PI ROBERT Clinton BARBER, NATHALIE SUMIEN · 2002 to 2026
$6.9M
NIA NIH HHS AG020494NIA NIH HHS T32 AG020494
6 · The paper itself

Abstract

rationaleRecreational and medical use of stimulants is increasing, and their use may increase susceptibility to aging and promote neurobehavioral impairments. The long-term consequences of these psychostimulants and how they interact with age have not been fully studied.

objectivesOur study investigated whether chronic exposure to the prototypical psychostimulant, methamphetamine (METH), at doses designed to emulate human therapeutic dosing, would confer a pro-oxidizing redox shift promoting long-lasting neurobehavioral impairments.

methodsGroups of 4-month-old male and female C57BL/6 J mice were administered non-contingent intraperitoneal injections of either saline or METH (1.4 mg/kg) twice a day for 4 weeks. Mice were randomly assigned to one experimental group: (i) short-term cognitive assessments (at 5 months), (ii) long-term cognitive assessments (at 9.5 months), and (ii) longitudinal motor assessments (at 5, 7, and 9 months). Brain regions were assessed for oxidative stress and markers of neurotoxicity after behavior testing.

resultsChronic METH exposure induced short-term effects on associative memory, gait speed, dopamine (DA) signaling, astrogliosis in females, and spatial learning and memory, balance, DA signaling, and excitotoxicity in males. There were no long-term effects of chronic METH on cognition; however, it decreased markers of excitotoxicity in the striatum and exacerbated age-associated motor impairments in males.

conclusionIn conclusion, cognitive and motor functions were differentially and sex-dependently affected by METH exposure, and oxidative stress did not seem to play a role in the observed behavioral outcomes. Future studies are necessary to continue exploring the long-term neurobehavioral consequences of drug use in both sexes and the relationship between aging and drugs.

Indexed as

Central Nervous System StimulantsMethamphetamineAnimalsCorpus StriatumDopamineFemaleMaleMiceMice, Inbred C57BLSex CharacteristicsCentral Nervous System StimulantsDopamineMethamphetamineAgingCognitionDopamineMethamphetamineMiceMotor functionOxidative stressPsychostimulants

Identifiers

PMID35347365
PMCPMC9232998
OpenAlexW4220791111

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.